Ontology highlight
ABSTRACT:
SUBMITTER: Kadowaki T
PROVIDER: S-EPMC5846888 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
Kadowaki Takashi T Inagaki Nobuya N Kondo Kazuoki K Nishimura Kenichi K Kaneko Genki G Maruyama Nobuko N Nakanishi Nobuhiro N Gouda Maki M Iijima Hiroaki H Watanabe Yumi Y
Diabetes, obesity & metabolism 20170915 2
Dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium glucose co-transporter 2 (SGLT2) inhibitors are frequently used in combination for the treatment of type 2 diabetes mellitus (T2DM). We examined the efficacy and safety of teneligliptin (a DPP-4 inhibitor) added to canagliflozin (an SGLT2 inhibitor) monotherapy in Japanese patients with poorly controlled T2DM as part of the development of a fixed-dose combination of teneligliptin and canagliflozin. Japanese patients treated with canagliflozin ...[more]